AUBRIE BIRD: Open Payments
NPI 1780454116 · LAWRENCE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$591 in 40 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $462 · 2025 $591
Food & beverage: $591
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $148 |
| Saluda Medical Americas, Inc. | 4 | $78 |
| Novo Nordisk Inc | 5 | $75 |
| Lilly USA, LLC | 5 | $73 |
| Astellas Pharma US Inc | 3 | $48 |
| SANOFI PASTEUR INC. | 1 | $29 |
| Boston Scientific Corporation | 1 | $23 |
| Hologic Sales and Service, LLC | 1 | $21 |
| Seqirus USA Inc | 1 | $21 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
Products named: QULIPTA, Evoke, UBRELVY, Veozah, Ozempic, MOUNJARO, JARDIANCE, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE.
Industry payments across KS — which companies pay providers there.
